We already know how to permanently fix hair loss. The science is done. The only thing missing is the funding to run one experiment.
I want to explain something that has been driving me insane.
We have been stuck with the same two treatments for decades. Finasteride, discovered by accident, lowers DHT and minoxidil, discovered by accident, grows hair through a mechanism we still don't fully understand. Both require lifelong use. Neither addresses the root cause. One messes with your systemic hormones while the other stops working the moment you quit.
Why is this still the standard of care in 2026? The answer is not that the science is too hard. The answer it seems is nobody has funded the one experiment that would unlock a permanent solution.
I think this might make what I think clear.
The single most important fact about hair loss that nobody talks about.
Every bald man has hair follicles on the back of his head that are completely immune to DHT. These follicles never miniaturize. They never fall out. They keep growing thick terminal hair until the day you die. We know this for a fact because hair transplant surgeons move these follicles to the top of the scalp and they just keep growing. They do not need finasteride to survive. They are naturally resistant. This means the cure for hair loss already exists on your own head. The resistant follicles have the same DNA as your bald follicles. Same genes, same person and same blood supply. The difference is entirely epigenetic. The resistant follicle reads the genome one way. The susceptible follicle reads it differently. Same book, different chapter.
If that is true, and it is, then the cure is not a drug you take forever. The cure must be a treatment that changes how your susceptible follicles read their own DNA. You flip them from the susceptible program to the resistant program. You do it once. The change is stable because epigenetic states are heritable across cell divisions. The follicle now reads DHT the way your donor area reads DHT. It ignores it.
Every technology to do this already exists.
This is not science fiction because every component required has been demonstrated.
Single-cell ATAC-seq can map exactly which genes are open and closed in individual cells. We can take a resistant follicle and a susceptible follicle from the same person and see every molecular difference between them. The technology has existed for years but it costs a few thousand dollars per sample.
Once you have that map, someone (maybe an AI model trained to do this) can identify the smallest number of changes needed to flip a susceptible cell into a resistant one. Which transcription factors need to be turned on. Which need to be silenced. This is causal inference on a regulatory network. The same computational tools already do this for cancer drug discovery. Nanoparticles in the 300 to 600 nanometer range naturally accumulate in hair follicles when applied topically. This has been demonstrated in multiple studies. You do not need to inject anything because you rub it on. The particles fall into the follicle opening and reach the dermal papilla at the base. We can load those particles with mRNA to turn on specific genes and siRNA to turn off specific genes. mRNA and siRNA therapies are already in clinical use. Lipid nanoparticles have established safety profiles from the COVID vaccines and cancer therapies.
So what is missing?
I believe a comprehensive single-cell comparison of resistant occipital follicles versus susceptible vertex follicles from the same individuals across a meaningful cohort. Roughly fifty men. Two small punch biopsies each. Single-cell ATAC-seq and RNA-seq on the dermal papilla cells. This experiment would cost somewhere in the low six figures. A few hundred thousand dollars which is pocket change compared to what gets spent on clinical trials for drugs that will never cure anything. Academic hair loss research has been trapped in the DHT suppression paradigm for thirty years.
What a permanent solution would actually look like.
You apply a topical formulation once. Maybe once a week for a month. The nanoparticles deliver a defined set of transcription factors and silencing RNAs to your dermal papilla cells. Over the course of a few weeks, the susceptible follicles shift their epigenetic state to match the resistant follicles on the back of your head. The change may be stable. Your follicles now read DHT the way your donor follicles read it. They stop miniaturizing, they recover over subsequent hair cycles and you do not need to keep applying anything. The cure is permanent because the epigenetic change is permanent.
For areas where follicles are completely gone, you would need a second component. Stem cell activation to wake up dormant miniaturized follicles, or cell therapy to repopulate empty sites. But for the majority of men who still have hair, however thin, the reprogramming alone would halt loss and recover significant density.
Why am I posting this here?
I want someone to explain why this hasn't been done, not why it might not work. We can argue about the specific transcription factors and delivery efficiency. That is what experiments are for. I want to know why the one experiment that would answer those questions has never been funded. Is there a technical barrier I am missing? Is someone already doing this and I haven't found it? Or is this genuinely a case where a solvable problem remains unsolved because the incentives of the research ecosystem do not align with solving it?
If you work in biotech, if you are a researcher, if you know someone who knows someone, tell me why this is not already underway. Because from where I stand, the science is done. The tools exist. The bottleneck is a single publicly available dataset that would cost less than a McMansion in the Bay Area. That cannot be the reason we are all still rubbing minoxidil on our heads and hoping for the best.